Thanks for the nice webinar, learn a lot. two questions, The Half days webinar recordings would be available? regarding HTN management,in reference to the explanation of the question , CKS states. 'Consider antihypertensive drug treatment in addition to lifestyle advice for people aged under 60 years with stage 1 hypertension and an estimated 10-year CVD risk below 10%. Bear in mind that 10-year cardiovascular risk may underestimate the lifetime probability of developing CVD.'' So what should be the right answer if we get similar question in exam? Thank you.
As you mentioned, the guideline mentions "consider" treatment in someone under 60 with a QRisk below 10%- it is up to us as clinicians to use our judgement and discuss here. The patient with a QRisk of 8.5% did not have any other risk factors so trying lifestyle changes and monitoring is a sensible approach. If I had a patient with a QRisk of 9.8%, or someone with additional risk factors I may discuss starting medication with the patient. I hope this helps!
Great session Dr Mahibur, your webinar has been very useful.
Glad to hear that Erwin!
Hello
Thank you - this has been so useful.
Just confused about over 80 - should we still be doing HBPM for them or just treat if clinic BP is >150/90
ABPM / HPBM is still needed for diagnosis. Once diagnosed, for those 80+ with clinic BP of 150/90+, consider treatment regardless of 10 year CVD risk.
Thanks for the nice webinar, learn a lot. two questions, The Half days webinar recordings would be available? regarding HTN management,in reference to the explanation of the question , CKS states. 'Consider antihypertensive drug treatment in addition to lifestyle advice for people aged under 60 years with stage 1 hypertension and an estimated 10-year CVD risk below 10%. Bear in mind that 10-year cardiovascular risk may underestimate the lifetime probability of developing CVD.'' So what should be the right answer if we get similar question in exam? Thank you.
The half day recording is available at
courses.emedica.co.uk/acatalog/MRCGP-AKT-Preparation-Masterclass-.html
As you mentioned, the guideline mentions "consider" treatment in someone under 60 with a QRisk below 10%- it is up to us as clinicians to use our judgement and discuss here. The patient with a QRisk of 8.5% did not have any other risk factors so trying lifestyle changes and monitoring is a sensible approach. If I had a patient with a QRisk of 9.8%, or someone with additional risk factors I may discuss starting medication with the patient. I hope this helps!